IN BRIEF: Ixico wins neuroimaging contracts worth over GBP1 million
Ixico PLC - London-based medical research company, focused on analysing trial data using neuroscience imaging and biomarkers - Signs two new commercial contracts worth approximately GBP1.3 million in total. First contract covers around three and a half years, with Ixico providing trial management and imaging analysis for a phase 1 study by "a major pharmaceutical company" on Alzheimer's disease. The second, under which Ixico will facilitate imaging data collection for a phase 1b trial to support surgical planning in Friedrich's ataxia, covers six years and is "with a US-based biotech". "This positive commercial momentum continues IXICO's successful execution of its 'Innovate, Lead, Scale' strategy to drive global expansion and growth," Ixico says. Read More